Cancer Research SABCS  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 5238-5244, October 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, L. W.
Right arrow Articles by Grisham, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, L. W.
Right arrow Articles by Grisham, J. W.

Clonal Cosegregation of Tumorigenicity with Overexpression of c-myc and Transforming Growth Factor {alpha} Genes in Chemically Transformed Rat Liver Epithelial Cells

Lester W. Lee1,2, Victoria W. Raymond, Ming-Sound Tsao, David C. Lee3, H. Shelton Earp4 and Joe W. Grisham1,5

Departments of Pathology [L. W. L., V. W. R., J. W. G.], Medicine [H. S. E.], and Microbiology and Immunology [D. C. L.] and Lineberger Comprehensive Cancer Center [D. C. L., J. W. G., H. S. E.], University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, and Department of Pathology, McGill University and Montreal General Hospital, Montreal, Quebec, Canada [M. S. T.]

Tumorigenicity was correlated with levels of expression of the genes for transforming growth factor {alpha} (TGF-{alpha}), epidermal growth factor receptor, c-myc, c-H-ras,, and c-K-ras in a series of 16 clonally derived transformed liver epithelial cell lines. The clonal lines, which varied in tumorigenicity from 0 to 97%, were established from a phenotypically heterogeneous population produced by repeated exposure of diploid WB-F344 (WB) cells to N-methyl-N'-nitro-N-nitrosoguanidine. Segregation of gene expression with tumorigenicity among clonal lines was determined by correlating rank orders of gene expression by clones relative to expression by wild-type WB cells. Only the expression of the c-myc gene correlated with tumorigenicity among all transformed clones. TGF-{alpha} gene expression was not correlated with tumorigenicity among all clones, but it was highly correlated with tumorigenicity among clones that expressed the c-myc gene above the median level for all clones (>5-fold the level of expression by WB cells). Even high levels of expression of the TGF-{alpha} gene (up to 60-fold the level of expression by WB cells) were not correlated with tumorigenicity among the clones expressing the c-myc gene at levels <5-fold the level of expression by WB cells. Clones which simultaneously overexpressed both c-myc and TGF-{alpha} genes at levels above the median levels for all clones were significantly more tumorigenic than were clones which expressed either or both genes at lower than median levels. These results suggest that overexpressed c-myc and TGF-{alpha} genes cooperate in their association with tumorigenicity. Most of the highly tumorigenic clones that overexpressed c-myc and TGF-{alpha} also overexpressed the c-H-ras and/or the c-K-ras genes; clones that overexpressed neither of the c-ras genes nor the genes for c-myc and TGF-{alpha} were not very tumorigenic, while clones that expressed one or both c-ras genes (but not both c-myc and TGF-{alpha}) were variably tumorigenic over an intermediate range.

1 Supported by NIH Grant CA 29323.

2 Present address: Department of Epidemiology, University of North Carolina at Chapel Hill, McGavran-Greenberg Hall, CB 7400, Chapel Hill, NC 27599.

3 Supported by NIH Grant CA 43793.

4 Supported by NIH Grants DK 30002 and DK 31683.

5 To whom requests for reprints should be addressed.

Received 4/23/91. Accepted 7/22/91.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. Kagawa, T. Sano, N. Ishibashi, M. Hashimoto, M. Okuno, H. Moriwaki, R. Suzuki, H. Kohno, and T. Tanaka
An acyclic retinoid, NIK-333, inhibits N-diethylnitrosamine-induced rat hepatocarcinogenesis through suppression of TGF-{alpha} expression and cell proliferation
Carcinogenesis, June 1, 2004; 25(6): 979 - 985.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
J I Goodman
Response to "Epigenetic Mechanisms of Carcinogenesis" by Kamendunlis JE, Kamendulis LM and Xu Y
Human and Experimental Toxicology, October 1, 2000; 19(10): 563 - 565.
[PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. D. McCullough, W. B. Coleman, S. L. Ricketts, J. W. Wilson, G. J. Smith, and J. W. Grisham
Plasticity of the neoplastic phenotype in vivo is regulated by epigenetic factors
PNAS, December 22, 1998; 95(26): 15333 - 15338.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. M. Howell, L. E. Humphrey, B. L. Ziober, R. Awwad, B. Periyasamy, A. Koterba, W. Li, J. K. V. Willson, K. Coleman, J. Carboni, et al.
Regulation of Transforming Growth Factor alpha  Expression in a Growth Factor-Independent Cell Line
Mol. Cell. Biol., January 1, 1998; 18(1): 303 - 313.
[Abstract] [Full Text]


Home page
Toxicol PatholHome page
G. J. Moser, D. C. Wolf, and T. L. Goldsworthy
Quantitative Relationship Between Transforming Growth Factor-Alpha and Hepatic Focal Phenotype and Progression in Female Mouse Liver
Toxicol Pathol, May 1, 1997; 25(3): 275 - 283.
[Abstract] [PDF]


Home page
DevelopmentHome page
L. Reneker, D. Silversides, K Patel, and P. Overbeek
TGF alpha can act as a chemoattractant to perioptic mesenchymal cells in developing mouse eyes
Development, January 6, 1995; 121(6): 1669 - 1680.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
Poster Session
Toxicol Pathol, November 1, 1993; 21(6): 623 - 646.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.